awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38260349-D44788B9-4332-433A-AF1A-AF4476D8EC40
Q38260349-D44788B9-4332-433A-AF1A-AF4476D8EC40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38260349-D44788B9-4332-433A-AF1A-AF4476D8EC40
Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin.
P2860
Q38260349-D44788B9-4332-433A-AF1A-AF4476D8EC40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38260349-D44788B9-4332-433A-AF1A-AF4476D8EC40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
946896afe0e1b493aeddbe5a3c5b1d4f053ff6b5
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus